Polar NanoPharma
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$21,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Polar NanoPharma is a biotechnology company that develops advanced nanoparticle-based drug delivery systems for oncology applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polar NanoPharma Comparables
Compare Polar NanoPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libera Bio | 87% | |
| QurCan Therapeutics | 83% | |
| InnoUp Farma | 77% | |
Polar NanoPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Pre Seed | Jan 1, 2026 | ||||
| Accelerator | Feb 20, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 192% MoM, reaching 587.
- May 27, 2026
$21K grant received from EmprendeXXI Awards and Spanish Chamber of Commerce.
Polar NanoPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Polar NanoPharma's valuation, stock price, and market status.